Related Experiment Video
Updated: Apr 19, 2026

Simulating Pancreatic Neuroplasticity: In Vitro Dual-neuron Plasticity Assay
Published on: April 14, 2014
Update on pancreatic neuroendocrine tumors
Logan R McKenna1, Barish H Edil1
1Department of Surgery, University of Colorado, Academic Office One, Aurora, CO, USA.
Abstract:
Pancreatic neuroendocrine tumors (pNETs) are relatively rare tumors comprising 1-2% of all pancreas neoplasms. In the last 10 years our understanding of this disease has increased dramatically allowing for advancements in the treatment of pNETs. Surgical excision remains the primary therapy for localized tumors and only potential for cure. New surgical techniques using laparoscopic approaches to complex pancreatic resections are a major advancement in surgical therapy and increasingly possible. With early detection being less common, most patients present with metastatic disease. Management of these patients requires multidisciplinary care combining the best of surgery, chemotherapy and other targeted therapies. In addition to surgical advances, recently, there have been significant advances in systemic therapy and targeted molecular therapy.
Insights
Pancreatic neuroendocrine tumors (pNETs) are rare. Advances in surgical techniques and systemic therapies are improving treatment for localized and metastatic pNETs, offering new hope for patients.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pancreatic neuroendocrine tumors (pNETs) represent 1-2% of pancreatic neoplasms.
- Recent advancements have significantly improved our understanding and treatment of pNETs.
- Most patients present with metastatic disease due to infrequent early detection.
Purpose of the Study:
- To review recent advancements in the treatment of pancreatic neuroendocrine tumors.
- To highlight the evolving role of surgical and systemic therapies in managing pNETs.
- To emphasize the importance of multidisciplinary care for patients with pNETs.
Main Methods:
- Review of recent literature on pancreatic neuroendocrine tumor treatment.
- Analysis of advancements in surgical techniques, including laparoscopic approaches.
- Evaluation of progress in systemic and targeted molecular therapies.
Main Results:
- Surgical excision remains the primary curative therapy for localized pNETs.
- Laparoscopic techniques are increasingly feasible for complex pancreatic resections.
- Significant progress has been made in systemic and targeted molecular therapies for metastatic pNETs.
Conclusions:
- Multidisciplinary care integrating surgery, chemotherapy, and targeted therapies is crucial for managing pNETs.
- Ongoing research and technological advancements continue to improve outcomes for pNET patients.
- Early detection remains a challenge, underscoring the need for improved diagnostic strategies.
Related Concept Videos
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
